Form 4 Tracker
Julie Rubinstein

President and COO · 19 filings · Latest: Oct 14, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Julie RubinsteinPresident and COOOct 2, 2026
Sale
$28.1311,881$334.2K377,802
ADPT
Julie RubinsteinPresident and COOOct 2, 2026
Option Exercise
$12.1411,881$144.2K389,683
ADPT
Julie RubinsteinPresident and COOOct 1, 2026
Sale
$28.0511,881$333.3K377,802
ADPT
Julie RubinsteinPresident and COOOct 1, 2026
Option Exercise
$12.1411,881$144.2K389,683
ADPT
JULIE RUBINSTEIN—Oct 1, 2026
Proposed Sale
$28.90379,777$11.0M—
ADPT
Julie RubinsteinPresident and COOApr 27, 2026
Sale
$14.2319,037$270.9K377,802
ADPT
Julie RubinsteinPresident and COOApr 27, 2026
Option Exercise
$8.4614,707$124.4K396,839
ADPT
Julie RubinsteinPresident and COOApr 24, 2026
Sale
$14.0219,060$267.2K382,132
ADPT
Julie RubinsteinPresident and COOApr 24, 2026
Option Exercise
$8.4614,722$124.5K401,192
ADPT
Julie RubinsteinPresident and COOApr 23, 2026
Sale
$13.7419,060$261.9K386,470
ADPT
Julie RubinsteinPresident and COOApr 23, 2026
Option Exercise
$8.4614,722$124.5K405,530
ADPT
Julie RubinsteinPresident and COOApr 22, 2026
Sale
$14.1319,060$269.3K390,808
ADPT
Julie RubinsteinPresident and COOApr 22, 2026
Option Exercise
$8.4614,722$124.5K409,868
ADPT
Julie RubinsteinPresident and COOApr 21, 2026
Sale
$14.6630,941$453.6K395,146
ADPT
Julie RubinsteinPresident and COOApr 21, 2026
Option Exercise
$10.1026,603$268.8K426,087
ADPT
Julie RubinsteinPresident and COOApr 20, 2026
Sale
$14.5519,060$277.3K399,484
ADPT
Julie RubinsteinPresident and COOApr 20, 2026
Option Exercise
$8.4614,722$124.5K418,544
ADPT
Julie RubinsteinPresident and COOApr 17, 2026
Sale
$14.5719,060$277.7K403,822
ADPT
Julie RubinsteinPresident and COOApr 17, 2026
Option Exercise
$8.4614,722$124.5K422,882
ADPT
Julie RubinsteinPresident and COOApr 16, 2026
Sale
$14.1819,060$270.3K408,160